Zurueck zur Suche

Reporte zur Charge U039726

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

17Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
KS 7 OH 4 MI 3 VA 1 MD 1 WV 1

VAERS 2639693

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

mild
Staat
OH
Alter
1,6
Geschlecht
M
Eingang
01.06.2023
Impfdatum
11.07.2022
Beginn
18.07.2022
Tage bis Beginn
7,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Post vaccination fever

Symptomtext

Postvaccination fever on 2022-07-18.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Post vaccination fever
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Acute atopic conjunctivitis, bilateral; Encounter for routine child health examination NOS; Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism; Encounter for screening for disorder due to exposure to contaminants; Need for immunization against single bacterial diseases
Vorgeschichte
-
Andere Medikamente
POLY-VI-SOL/IRON 11 MG/ML ORAL SOLN
Allergien
-
Vorherige Impfungen
-

VAERS 2456025

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

mild
Staat
VA
Alter
34,0
Geschlecht
F
Eingang
23.09.2022
Impfdatum
04.08.2022
Beginn
05.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cellulitis Rash Rash erythematous Rash pruritic Skin warm

Symptomtext

Red bump appears the next day that was itchy. I figured it was a local reaction. The bump grew bigger each day and became painful, and warm to the touch. Went to urgent care 8/8/22. Diagnosed with cellulitis and given Keflex antibiotic.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
Insomnia, ADHD, High Heart Rate
Andere Medikamente
Metoprolol, Trazadone, Prenatal Vitamin, Celexa, Reglan, and ibuprofen (taken the night before around 9pm)
Allergien
N/A
Vorherige Impfungen
-

VAERS 2519987

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
MI
Alter
37,0
Geschlecht
F
Eingang
30.11.2022
Impfdatum
15.11.2022
Beginn
15.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

Patient was given Varicella vaccine on 11/15/2022 not knowing the patient had received another live vaccine-MMR on 11/03/2022 in another facility which invalidated her Varicella vaccine. No reaction was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
amlodipine norethindrone
Allergien
Sulfa Antibiotics
Vorherige Impfungen
-

VAERS 2516237

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
KS
Alter
0,9
Geschlecht
U
Eingang
25.11.2022
Impfdatum
15.09.2022
Beginn
15.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; VARIVAX that had undergone temperature excursion; This spontaneous report has been received from a registered nurse concerning a 11-month-old patient of unknown gender. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported. On an unknown date, a temperature excursion occurred for varicella virus vaccine live (oka/merck) (VARIVAX), in a timeframe of 1 hour and 45 minutes. A previous temperature excursion was also reported. On 15-SEP-2022, the patient received a vaccine dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U039726, expiration date: 15-DEC-2023) (dose, route of administration and anatomical location were not provided) as prophylaxis (product storage error). No additional events were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2493674

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
KS
Alter
1,0
Geschlecht
U
Eingang
31.10.2022
Impfdatum
12.09.2022
Beginn
12.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; HCP reporting an improperly stored vaccine was administered to a patient.; This spontaneous report was received from registered nirse and refers to a 12-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 12-SEP-2022, improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U039726, expiration date: 15-DEC-2023, administered for prophylaxis (dose, route of administration and anatomical location were not provided) was administered to the patient. The vaccine experienced a temperature excursion of minus 11.8 degree Celsius for 1 hour and 45 minutes (product storage error). There was no previous temperature excursion. No additional adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2210USA000872: US-009507513-2210USA001538: US-009507513-2210USA001524: US-009507513-2210USA001062: US-009507513-2210USA001278: US-009507513-2210USA000999: US-009507513-2210USA001209: US-009507513-2210USA001904:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472217

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
KS
Alter
1,0
Geschlecht
U
Eingang
29.10.2022
Impfdatum
16.09.2022
Beginn
16.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Product storage error

Symptomtext

No additional AE; Customer called for a temperature excursion in case 02261220. Caller reported that VARIVAX that had undergone temperature; Inappropriate age at vaccine administration; This spontaneous report was received from a registered nurse, referring to a 12-month-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported. On 16-SEP-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (strength, vaccination scheme, anatomical site of vaccination, and route of administration were not reported; lot number U039726, expiration date was reported and validated as 15-DEC-2023) as prophylaxis, that undergone a temperature excursion (product storage error and product administered to patient of inappropriate age). No additional adverse event reported. The vaccine experienced a temperature excursion of minus (-) 11.8 degrees Celsius (C) for 1 hour and 45 minutes. There was a previous temperature excursion.; Sender's Comments: US-009507513-2210USA001062: US-009507513-2210USA000872:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472217

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
KS
Alter
1,0
Geschlecht
U
Eingang
29.10.2022
Impfdatum
16.09.2022
Beginn
16.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Product storage error

Symptomtext

No additional AE; Customer called for a temperature excursion in case 02261220. Caller reported that VARIVAX that had undergone temperature; Inappropriate age at vaccine administration; This spontaneous report was received from a registered nurse, referring to a 12-month-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported. On 16-SEP-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (strength, vaccination scheme, anatomical site of vaccination, and route of administration were not reported; lot number U039726, expiration date was reported and validated as 15-DEC-2023) as prophylaxis, that undergone a temperature excursion (product storage error and product administered to patient of inappropriate age). No additional adverse event reported. The vaccine experienced a temperature excursion of minus (-) 11.8 degrees Celsius (C) for 1 hour and 45 minutes. There was a previous temperature excursion.; Sender's Comments: US-009507513-2210USA001062: US-009507513-2210USA000872:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2471249

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
29.10.2022
Impfdatum
08.09.2022
Beginn
08.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Product storage error

Symptomtext

No addittional AE; Customer called for a temperature excursion in case 02261220. Caller reported that VARIVAX that had undergone temperature; was administered to a patient on 08-SEP-2022; This spontaneous report was received from a registered nurse, referring to a 6-day-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported. On 08-SEP-2022, the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) (strength, vaccination scheme, anatomical site of vaccination, and route of administration were not reported; lot number U039726, expiration date was reported and validated as 15-DEC-2023) as prophylaxis (product administered to patient of inappropriate age), that undergone a temperature excursion (product storage error). No additional adverse event reported. The vaccine experienced a temperature excursion of minus (-) 11.8 degrees Celsius (C) for 1 hour and 45 minutes. There was a previous temperature excursion.; Sender's Comments: US-009507513-2210USA001062: US-009507513-2210USA000872:MSD

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2471249

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
29.10.2022
Impfdatum
08.09.2022
Beginn
08.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Product storage error

Symptomtext

No addittional AE; Customer called for a temperature excursion in case 02261220. Caller reported that VARIVAX that had undergone temperature; was administered to a patient on 08-SEP-2022; This spontaneous report was received from a registered nurse, referring to a 6-day-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported. On 08-SEP-2022, the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) (strength, vaccination scheme, anatomical site of vaccination, and route of administration were not reported; lot number U039726, expiration date was reported and validated as 15-DEC-2023) as prophylaxis (product administered to patient of inappropriate age), that undergone a temperature excursion (product storage error). No additional adverse event reported. The vaccine experienced a temperature excursion of minus (-) 11.8 degrees Celsius (C) for 1 hour and 45 minutes. There was a previous temperature excursion.; Sender's Comments: US-009507513-2210USA001062: US-009507513-2210USA000872:MSD

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2483558

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
KS
Alter
3,0
Geschlecht
U
Eingang
20.10.2022
Impfdatum
30.09.2022
Beginn
30.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported.; vaccine administered after temperature excursion; This spontaneous report was received from a nurse, concerning a 3-year-old patient of unknown gender. Information regarding the patients' medical history, concurrent conditions, drug reactions or allergies, and concomitant therapies was not provided. On an unknown date, there was a temperature excursion registered for varicella virus vaccine live (oka/merck) (VARIVAX) of -11.8 Celsius degrees for 1 hour 45 minutes and 0 seconds. It was reported that there was no previous temperature excursion reported (conflicting information, also reported previous temperature excursion as "yes"). On 30-SEP-2022, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot # U039726, expiration date 15-DEC-2023, (dose, route of administration, and anatomical location were not provided) administered for prophylaxis (product storage error). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2400383

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u039726

gering
Staat
MI
Alter
1,5
Geschlecht
M
Eingang
03.08.2022
Impfdatum
26.07.2022
Beginn
26.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Patient was given Proquad instead of MMR. Patient also received Varivax separately on the same day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Mefloquine, MVI
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2373286

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
19.07.2022
Impfdatum
02.06.2022
Beginn
02.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse event reported; HBP reported an adverse event. Caller stated VARIVAX was administered after a temperature excursion. No additional AE or PQC reported. No additional information provided. ? Names of vaccines involved (including lot/exp): VARIVAX Lot U039726, E; This spontaneous report has been received from an office manager, regarding an identified patient of unknown gender and age. Information regarding the patient's historical conditions, past drugs reactions or allergies, concurrent conditions or concomitant therapies was not provided. On unspecified dates, the varicella virus vaccine live (Oka/Merck) (VARIVAX) lot # U039726 experienced a temperature excursion of -13.5 Celsius degrees (C) for a timeframe of 1 hour 0 minutes and 0 seconds; no previous excursions of temperature for this lot number. If a digital data logger was involved was not reported (product storage error) (product storage error). Consequently, on 02-JUN-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous Injection, (lot number U039726 confirmed to be a valid lot with expiration date reported and stablished as 15-DEC-2023) administered as prophylaxis (strength, dose, vaccination scheme, route of administration and anatomical location were not provided) (product storage error). No additional adverse events (AE) reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2373285

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
19.07.2022
Impfdatum
27.06.2022
Beginn
27.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse event reported; HBP reported an adverse event. Caller stated VARIVAX was administered after a temperature excursion. No additional AE or PQC reported. No additional information provided. ? Names of vaccines involved (including lot/exp): VARIVAX Lot U039726, E; This spontaneous report has been received from an office manager, regarding an identified patient of unknown gender and age. Information regarding the patient's historical conditions, past drugs reactions or allergies, concurrent conditions or concomitant therapies was not provided. On unspecified dates, the varicella virus vaccine live (Oka/Merck) (VARIVAX) lot # U039726 experienced a temperature excursion of -11.5 Celsius degrees (C) for a timeframe of 2 hour 40 minutes and 0 seconds; with a previous temperature excursion of -14 C for a timeframe of 1 hour 0 minutes and 0 seconds, and another of -13.5 C for a timeframe of 1 hour 0 minutes and 0 seconds. If a digital data logger was involved was not reported (product storage error). Consequently, on 27-JUN-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number U039726 confirmed to be a valid lot with expiration date reported and stablished as 15-DEC-2023) administered as prophylaxis (formulation, strength, dose, vaccination scheme, route of administration and anatomical location were not provided) (product storage error). No additional adverse events (AE) reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2371340

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
16.07.2022
Impfdatum
02.06.2022
Beginn
02.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; HBP reported an adverse event. Caller stated VARIVAX was administered after a temperature excursion. No additional AE or PQC reported. No additional information provided. ? Names of vaccines involved (including lot/exp): VARIVAX Lot U039726, E; This spontaneous report has been received from a nurse, regarding a patient of unknown age and gender. The patient's pertinent medical history, current conditions, previous drug reactions or allergies, and concomitant medications were not reported. On 02-JUN-2022, the patient was vaccinated with improperly storage dose varicella virus vaccine live (Oka/Merck) (VARIVAX) as prophylaxis (lot number: U039726, which was determined to be valid, with an expiration date on 15-DEC-2023) (strength, dose, route and anatomical location of administration were not provided) (product storage error). Administered dose underwent a temperature excursion of -13,5 degrees Celsius (C) for 1 hour. It was reported that there was not any previous temperature excursion. No additional adverse event was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2371322

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
MD
Alter
1,0
Geschlecht
F
Eingang
16.07.2022
Impfdatum
20.06.2022
Beginn
30.06.2022
Tage bis Beginn
10,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose Incorrect route of product administration No adverse event Product preparation error

Symptomtext

The patient has had no side effects at this time.; PEDVAX HIB was accidently used as the diluent for MMR-II and VARIVAX instead of the Merck sterile diluent; Because of the PEDVAX HIB being used as the diluent for both MMR-II and VARIVAX, the patient received 1mL of PEDVAX HIB instead of the recommended dose of 0.5mL therefore receiving double the recommended dose of PEDVAX HIB.; Also, the PEDVAX HIB was given subcutaneously instead of intramuscularly since it was mixed as diluent with MMR-II and VARIVAX.; This spontaneous report was received from physician and refers to a 12-month-old female patient. The patient's concomitant therapy included pneumococcal vaccine conj 13v (crm197) (PREVENAR 13). The patient's concurrent conditions, medical history, allergies and drug reactions were not provided. On 30-JUN-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) , 0.5 ml, administered subcutaneously, lot #U011995, expiration date: 15-APR-2023 (strength and dose number was not provided), and varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 ml, administered subcutaneously, lot #U039726, expiration date: 15-DEC-2023 (strength and dose number were not provided) for prophylaxis. Haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot #U039951, expiration date: 22-JUN-2024 was accidentally used as the diluent for both measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX) instead of Merck sterile diluen (product preparation error). Because haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) being used as the diluent for both measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX), the patient received 1 ml of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) instead of recommended dose of 0.5 ml, therefore receiving double the recommended dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (accidental overdose). Also, the haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) was given subcutaneously instead of intramuscularly since it was mixed as diluent with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX) (incorrect route of product administration). The patient has had no side effects at this time (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2341817

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u039726

gering
Staat
MI
Alter
17,0
Geschlecht
M
Eingang
29.06.2022
Impfdatum
08.06.2022
Beginn
08.06.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

Client came into the clinic for vaccinations on 6/8/22 with his guardian. This nurse reviewed the available record to determine what vaccines the child was to receive, per protocol. According to the only records available, after reviewing records multiple times, it was determined that that child needed Tdap, IPV, MMR, Varicella, Hep A, MenB, flu, and HPV. The client tolerated well the injections with no complications. Once the client left the office, this nurse had a conversation with the clinic support supervisor and the immunization supervisor and it was communicated at that time that the child had multiple records prior to this appointment. The clinic support supervisor had called records, rather than fill out a petition change form, to have the records merged and the result was an incorrect merge of the duplicate records. When the records were merged there were many vaccines that did not transfer over. Therefore, the "updated" record showed that he was incomplete with Tdap, IPV, MMR, Varicella, Hep A, MenB, flu, and HPV. With no documentation that this merge had occurred in the chart, the only records this nurse had to evaluate to determine what the child was due for was the "updated" record and the chart. Because of this, the child received Tdap, IPV, MMR, Varicella, Hep A, MenB, flu, and HPV. Now that the records have been corrected, it shows that the child received additional doses of MMR, Varicella, MenB, flu, and HPV that he did not need. Child's guardian was notified. No adverse events were reported. Child tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2313232

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039726

gering
Staat
WV
Alter
1,3
Geschlecht
M
Eingang
08.06.2022
Impfdatum
08.06.2022
Beginn
08.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

NONE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
SICK APPT 5/20/22 - ACUTE UPPER RESPIRATORY INFECTION/CROUP
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-